← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2003Last known activity
Jul 29, 2021
Timeline
1990s
- Jun 1, 1999
AnGes, Inc.— Founded
Drugs by trial phase (5 distinct, 10 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (15)
- NCT04993586Lead sponsorPhase 1/Phase 2Jul 29, 2021
- NCT04993586Study directorPhase 1/Phase 2Jul 29, 2021
- NCT04655625Study directorPhase 2/Phase 3Nov 23, 2020
- NCT04655625Lead sponsorPhase 2/Phase 3Nov 23, 2020
- NCT04527081Study directorPhase 1/Phase 2Aug 31, 2020
- NCT04527081Lead sponsorPhase 1/Phase 2Aug 31, 2020
- NCT04463472Study directorPhase 1/Phase 2Jun 29, 2020
- NCT04463472Lead sponsorPhase 1/Phase 2Jun 29, 2020
- NCT04267640Lead sponsorPhase 2Jan 30, 2020
- NCT03263611Lead sponsorPhase 1Feb 26, 2018
- NCT03263611Study directorPhase 1Feb 26, 2018
- NCT02144610Lead sponsorPhase 3Oct 1, 2014
- NCT02016755Lead sponsorPhase 2Nov 1, 2013
- NCT00189540Lead sponsorPhase 2Aug 1, 2005
- NCT00060892Lead sponsorPhase 2Apr 1, 2003
Details
- Founded
- Tokyo, JP Jun 1, 1999
- Last known activity
- Jul 29, 2021